Chunghwa Chemical Synthesis & Biotech Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chunghwa Chemical Synthesis & Biotech Co Ltd with three other
companies in this sector in TAIWAN :
Savior Lifetec Corp
sales of 1.32 billion Taiwanese Dollars [US$46.10 million]
of which 100%
was Drugs Development, Production and Sales),
Syngen Biotech Co Ltd
(1.30 billion Taiwanese Dollars [US$45.35 million]
of which 99%
was Functional Food and Mupirocin), and
Panion & Bf Biotech Inc.
(1.57 billion Taiwanese Dollars [US$55.03 million]
of which 77%
During the year ended December of 2019, sales at
Chunghwa Chemical Synthesis & Biotech Co Ltd were 1.16 billion Taiwanese Dollars (US$40.44 million).
increase of 13.5%
versus 2018, when the company's sales were 1.02 billion Taiwanese Dollars .
Despite this increase, sales are still
below the level achieved in 2017, when Chunghwa Chemical Synthesis & Biotech Co Ltd
reported sales of 1.17 billion Taiwanese Dollars .
Sales of Taiwan saw an increase
19.7% in 2019, from
522.27 million Taiwanese Dollars to 625.31 million Taiwanese Dollars .